Shulin Wu
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 5
-
- Prostate Cancer Diagnosis and Treatment 29
- Prostate Cancer Treatment and Research 29
- Renal cell carcinoma treatment 12
- Urology top 5%
- Oncology top 10%
-
- Renal and related cancers 7
- Epigenetics and DNA Methylation 4
-
- Urologic and reproductive health conditions 11
-
- Bladder and Urothelial Cancer Treatments 10
- Co-authors
- Chin‐Lee WuW. Scott McDougalAria F. OlumiDouglas M. DahlRobert H. YoungBrendan D. ManningJingxiang HuangDavid B. Shackelford
- Journals
- Proceedings of the National Academy of Sciences (2 papers)Nature Communications (2 papers)Journal of Clinical Oncology (1 paper)
- Partner nations
- United StatesChinaSweden
In The Last Decade
Shulin Wu
59 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 97
- Cancer Research 419
- Pulmonary and Respiratory Medicine 691
- Urology 90
- Oncology 342
- Molecular Biology 670
Countries citing papers authored by Shulin Wu
This map shows the geographic impact of Shulin Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shulin Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shulin Wu more than expected).
Fields of papers citing papers by Shulin Wu
This network shows the impact of papers produced by Shulin Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shulin Wu. The network helps show where Shulin Wu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shulin Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 0 | |
| 3 | 2023 | 4 | |
| 4 | Dissecting the immune suppressive human prostate tumor microenvironment via integrated single-cell and spatial transcriptomic analysesbreakdown → | 2023 | 126 |
| 5 | 2023 | 1 | |
| 6 | 2022 | 4 | |
| 7 | 2022 | 1 | |
| 8 | 2020 | 22 | |
| 9 | 2020 | 18 | |
| 10 | 2020 | 9 | |
| 11 | 2018 | 13 | |
| 12 | 2018 | 41 | |
| 13 | 2017 | 49 | |
| 14 | 2016 | 50 | |
| 15 | 2015 | 11 | |
| 16 | 2015 | 11 | |
| 17 | 2015 | 28 | |
| 18 | 2015 | 32 | |
| 19 | 2012 | 24 | |
| 20 | 2010 | 120 |
About Shulin Wu
Shulin Wu is a scholar working on Pulmonary and Respiratory Medicine, Urology and Rheumatology, having authored 63 papers that have together received 1.6k indexed citations. Recurring topics across this work include Prostate Cancer Diagnosis and Treatment (29 papers), Prostate Cancer Treatment and Research (29 papers), Renal cell carcinoma treatment (12 papers), Urologic and reproductive health conditions (11 papers), Bladder and Urothelial Cancer Treatments (10 papers), Renal and related cancers (7 papers), Cancer Genomics and Diagnostics (5 papers) and Epigenetics and DNA Methylation (4 papers). The work is most often cited by research in Cancer Research (419 citations), Pulmonary and Respiratory Medicine (691 citations) and Urology (90 citations). Shulin Wu has collaborated with scholars based in United States, China and Sweden. Frequent co-authors include Chin‐Lee Wu, W. Scott McDougal, Aria F. Olumi, Douglas M. Dahl, Robert H. Young, Brendan D. Manning, Jingxiang Huang, David B. Shackelford, Mathias Leblanc and Chaofu Wang. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.